The Globe and Mail highlights RBC's investment in new Lumira venture fund

Ontario Industry Updates
Written By Maura Campbell
Lumira Logo.png

The Globe and Mail recently profiled Royal Bank of Canada's undisclosed investment in the country’s largest life sciences venture capital fund in two decades. Lumira is raising its fourth fund with a target of reaching US$200-million to back Canadian and U.S. drug and medical technology developers.

Maura Campbell
Previous

Flosonics Medical Closes US$14M Financing Round and Expands Board of Directors
Next

Globe and Mail features Providence Therapeutics in column, ‘Now we know why we need a vaccine industry in Canada'